References
Eldor A, Fridman R, Vlodvasky I, Hy-Am E, Fuks Z, Panet A (1984) Interferon enhances prostacyclin production by cultured vascular endothelial cells. J Clin Invest 73:251–257
Ezekowitz RAB, Mulliken JB, Folkman J (1992) Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy. N Engl J Med 326:1456–1464
Folkman J (1989) Successful treatment of an angiogenic disease. N Engl J Med 320:1211–1212
Larson EC, Zinkham WH, Eggleston JC, Zitelli BJ (1987) Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics 79:971–980
Özsoylu S, Irken G, Gürgey A (1989) High dose intravenous methylprednisolone for Kasabach-Merritt syndrome. Eur J Pediatr 148:403–405
Warrell RP, Kempin SJ (1985) Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med 313:309–312
White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A (1991) Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 118:59–66
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klein, C., Hauser, M. & Hadorn, H.B. Interferon alpha-2a therapy of consumptive coagulopathy in Kasabach-Merritt syndrome. Eur J Pediatr 151, 919 (1992). https://doi.org/10.1007/BF01954133
Issue Date:
DOI: https://doi.org/10.1007/BF01954133